William Blair Initiates Coverage on The Pennant Group (NASDAQ:PNTG)

Analysts at William Blair assumed coverage on shares of The Pennant Group (NASDAQ:PNTG) in a research report issued on Monday, MarketBeat.com reports. The brokerage set an “outperform” rating on the stock.

PNTG has been the topic of several other reports. Zacks Research raised shares of The Pennant Group from a “hold” rating to a “strong-buy” rating in a research report on Thursday, November 20th. Wall Street Zen raised shares of The Pennant Group from a “hold” rating to a “buy” rating in a report on Monday, November 24th. Wells Fargo & Company upgraded The Pennant Group from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $29.00 to $31.00 in a report on Tuesday, November 18th. Stephens restated an “overweight” rating and issued a $40.00 price objective on shares of The Pennant Group in a research note on Thursday, October 9th. Finally, Royal Bank Of Canada raised their price objective on The Pennant Group from $34.00 to $39.00 and gave the company an “outperform” rating in a research report on Monday, November 17th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $34.80.

The Pennant Group Stock Performance

Shares of NASDAQ PNTG opened at $28.90 on Monday. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.04 and a current ratio of 1.04. The stock has a 50 day moving average price of $25.83 and a 200 day moving average price of $25.73. The stock has a market capitalization of $999.77 million, a PE ratio of 38.53, a price-to-earnings-growth ratio of 2.33 and a beta of 1.31. The Pennant Group has a 52 week low of $21.18 and a 52 week high of $31.39.

The Pennant Group (NASDAQ:PNTG) last posted its quarterly earnings results on Wednesday, November 5th. The company reported $0.30 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.01. The firm had revenue of $229.04 million for the quarter, compared to analyst estimates of $221.96 million. The Pennant Group had a return on equity of 9.37% and a net margin of 3.15%.The Pennant Group has set its FY 2025 guidance at 1.140-1.180 EPS. Analysts predict that The Pennant Group will post 0.75 earnings per share for the current fiscal year.

Hedge Funds Weigh In On The Pennant Group

Institutional investors and hedge funds have recently made changes to their positions in the company. Ophir Asset Management Pty Ltd lifted its holdings in shares of The Pennant Group by 403.9% during the second quarter. Ophir Asset Management Pty Ltd now owns 1,048,759 shares of the company’s stock worth $31,305,000 after buying an additional 840,642 shares in the last quarter. WCM Investment Management LLC bought a new stake in shares of The Pennant Group in the third quarter valued at approximately $16,100,000. 8 Knots Management LLC grew its position in The Pennant Group by 23.9% during the first quarter. 8 Knots Management LLC now owns 3,014,023 shares of the company’s stock worth $75,803,000 after buying an additional 581,313 shares in the last quarter. Ameriprise Financial Inc. bought a new position in The Pennant Group during the 2nd quarter worth $14,356,000. Finally, Nuveen LLC bought a new position in The Pennant Group during the 1st quarter worth $9,181,000. Institutional investors and hedge funds own 85.88% of the company’s stock.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.